scholarly journals P2.09-03 Prognostic Value of Mutated KRAS in Circulating Tumor DNA Prior to Therapy in Patients with Lung Adenocarcinoma

2019 ◽  
Vol 14 (10) ◽  
pp. S769
Author(s):  
S.G.F. Wahl ◽  
H.Y. Dai ◽  
E.F. Emdal ◽  
A.L. Ottestad ◽  
E. Richardsen ◽  
...  
Keyword(s):  
Lung Adenocarcinoma ◽  
Prognostic Value ◽  
Circulating Tumor Dna ◽  
Tumor Dna

scholarly journals Prognostic value of baseline and 3 months postoperative circulating tumor DNA (ctDNA) in ovarian cancer patients

2021 ◽  
Author(s):  
Yoo-Na Kim ◽  
Jinho Heo ◽  
Jung-Yun Lee ◽  
Seung-Tae Lee ◽  
Saeam Shin ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cancer Patients ◽  
Prognostic Value ◽  
Circulating Tumor Dna ◽  
Tumor Dna

scholarly journals Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review

PLoS ONE ◽  
2017 ◽  
Vol 12 (2) ◽  
pp. e0171991 ◽  
Author(s):  
Gaowei Fan ◽  
Kuo Zhang ◽  
Xin Yang ◽  
Jiansheng Ding ◽  
Zujian Wang ◽  
...  
Keyword(s):  
Systematic Review ◽  
Colon Cancer ◽  
Prognostic Value ◽  
Circulating Tumor Dna ◽  
Tumor Dna

scholarly journals Novel SPECC1L-MET Fusion Detected in Circulating Tumor DNA in a Patient with Lung Adenocarcinoma following Treatment with Erlotinib and Osimertinib

2019 ◽  
Vol 14 (2) ◽  
pp. e27-e29 ◽  
Author(s):  
Annie W. Nelson ◽  
Alexa B. Schrock ◽  
Dean C. Pavlick ◽  
Siraj M. Ali ◽  
Emily C. Atkinson ◽  
...  
Keyword(s):  
Lung Adenocarcinoma ◽  
Circulating Tumor Dna ◽  
Tumor Dna

scholarly journals Circulating Tumor DNA Identifies EGFR Coamplification as a Mechanism of Resistance to Crizotinib in a Patient with Advanced MET-Amplified Lung Adenocarcinoma

2017 ◽  
Vol 12 (10) ◽  
pp. e155-e157 ◽  
Author(s):  
Ibiayi Dagogo-Jack ◽  
David Fabrizio ◽  
Jochen Lennerz ◽  
Alexa B. Schrock ◽  
Lauren Young ◽  
...  
Keyword(s):  
Lung Adenocarcinoma ◽  
Circulating Tumor Dna ◽  
Mechanism Of Resistance ◽  
Tumor Dna

Non-Invasive Monitoring of Urinary KRAS Circulating Tumor DNA for Treatment Response and Minimal Residual Disease in Patients with Lung Adenocarcinoma.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e19092-e19092 ◽  
Author(s):  
James Michael Randall ◽  
Mark G. Erlander ◽  
Cecile Rose T. Vibat ◽  
Saege Hancock ◽  
Vlada Melnikova ◽  
...  
Keyword(s):  
Lung Adenocarcinoma ◽  
Treatment Response ◽  
Minimal Residual Disease ◽  
Residual Disease ◽  
Circulating Tumor Dna ◽  
Invasive Monitoring ◽  
Non Invasive ◽  
Tumor Dna ◽  
Minimal Residual

Circulating tumor DNA sequencing to reveal the genomic complexity of advanced EGFR-mutant lung adenocarcinoma.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e23079-e23079
Author(s):  
Collin M. Blakely ◽  
Kimberly C. Banks ◽  
Richard Burnham Lanman ◽  
Jonathan Riess ◽  
Philip C. Mack ◽  
...  
Keyword(s):  
Dna Sequencing ◽  
Lung Adenocarcinoma ◽  
Circulating Tumor Dna ◽  
Genomic Complexity ◽  
Egfr Mutant ◽  
Tumor Dna
Sign in / Sign up

Export Citation Format

Share Document